Breast Cancer
Intramedullary spinal cord metastasis marks the end of disease course
Published in Clinical Oncology Week, March 17th, 2003
"Intramedullary spinal cord metastases (ISCM) are usually the result of rapidly progressing systemic malignancy. Breast cancer is one of the most common solid tumors with a high propensity of CNS dissemination. In the present report we describe two new cases with advanced breast cancer developing ISCM after a variable disease course," researchers in Greece report.
"One of these patients had brain metastasis at presentation, and while in relapse developed leptomeningeal carcinomatosis which was treated successfully; but it was followed shortly, as a terminal event, by ISCM and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Bone Tumors
Benign tumors in children can have serious diagnostic complications - Hysterectomy
Tamoxifen appears to be highly effective only against high-risk breast cancer - Cancer Mental Health
Screening test can help identify cancer survivors at risk for emotional distress - Colorectal Cancer Risk
High-isothiocyanate diet lowers risk in GST polymorphism-null patients - Cranial Surgery
Advances in surgical techniques can facilitate favorable cosmetic outcomes - Alcohol-Related Carcinogenesis
Retinoic acid is important in preventing alcohol-related carcinogenesis - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
